CTF1

Chr 16

cardiotrophin 1

Also known as: CT-1, CT1

The protein is a secreted cytokine that induces cardiac myocyte hypertrophy and activates the ILST/gp130 receptor. Mutations cause cardiofaciocutaneous syndrome, a RASopathy characterized by congenital heart defects, distinctive facial features, and skin abnormalities with autosomal dominant inheritance. The gene is not highly constrained against loss-of-function variants.

GeneReviewsOMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 1.74
Clinical SummaryCTF1
🧬
Gene-Disease Validity (ClinGen)
dilated cardiomyopathy · ADLimited

Limited evidence — not for standalone diagnostic reporting

Population Constraint (gnomAD)
Low constraint (pLI 0.04) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
12 unique Pathogenic / Likely Pathogenic· 148 VUS of 253 total submissions
📖
GeneReview available — CTF1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.74LOEUF
pLI 0.042
Z-score 0.51
OE 0.68 (0.271.74)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.81Z-score
OE missense 0.66 (0.490.90)
29 obs / 44.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.68 (0.271.74)
00.351.4
Missense OE0.66 (0.490.90)
00.61.4
Synonymous OE0.94
01.21.6
LoF obs/exp: 2 / 2.9Missense obs/exp: 29 / 44.2Syn Z: 0.22
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedCTF1-related dilated cardiomyopathyOTHERAD
DN
0.6162th %ile
GOF
0.75top 25%
LOF
0.3648th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

253 submitted variants in ClinVar

Classification Summary

Pathogenic11
Likely Pathogenic1
VUS148
Likely Benign78
Benign3
Conflicting10
11
Pathogenic
1
Likely Pathogenic
148
VUS
78
Likely Benign
3
Benign
10
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
11
0
11
Likely Pathogenic
0
0
1
0
1
VUS
12
123
12
1
148
Likely Benign
0
4
15
59
78
Benign
0
0
2
1
3
Conflicting
10
Total121274161251

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CTF1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →